Role of Transposable Elements in Septic Immune Aging
University of California, San Francisco · with National Cancer Institute (NCI) · NCT06809868
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 116
- US sites recruiting
- 1
- Study start
- February 14, 2025
- Record last updated
- January 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this observational study is to learn about how transposable element levels affect the patient outcomes in sepsis. The main questions it aims to answer is:
- Do transposable elements prematurely age the immune systems of patients with sepsis?
- Do transposable elements correlate with increased mortality in patients with sepsis in the ICU?
- Do transposable elements correlate with increased amount of secondary infections in patients with sepsis in the ICU?
Participants will have blood drawn from them but will not be subjected to additional interventions.
Being studied: RNA and DNA Sequencing
Conditions: Sepsis; Sepsis and Septic Shock; Sepsis With Multiple Organ Dysfunction (MOD); Sepsis With Acute Organ Dysfunction; Sepsis, Severe; Sepsis at Intensive Care Unit; Sepsis, Severe Sepsis and Septic Shock; Sepsis, Septic Shock
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age 18 or older
- Admitted to ICU with sepsis (Sepsis 3 Criteria)
- SOFA score of at least 2 at time of enrollment
Exclusion Criteria
- Patients on organ transplantation immunosuppression
- Patients with preexisting leukopenia
- Cancer patients receiving CAR-T therapy
- Patients who are under 18 years of age or otherwise deemed pediatric
- Patients with an ongoing bleeding diathesis (ie: DIC, hemorrhagic shock)
- Patients with a chronic hemoglobin below 7.0
- Patients who, prior to their ICU admission, are blood transfusion dependent
Recruiting US locations
University of California, San Francisco
San Francisco, CA 94143
Site contact: Alexendar R Perez, M.D., Ph.D · 415-476-1000 · Alexendar.Perez@ucsf.edu
Study contacts (from the official record)
- Alexendar R Perez, M.D., Ph.D · 415-476-1000 · Alexendar.Perez@ucsf.edu
- Matthieu Legrand, M.D., Ph.D · 415-476-1000 · matthieu.legrand@ucsf.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55